Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed refractory low-grade glioma

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 36; no. 15_suppl; p. 10506
Main Authors Kieran, Mark W., Bouffet, Eric, Broniscer, Alberto, Cohen, Kenneth J., Geoerger, Birgit, Hansford, Jordan R., Hingorani, Pooja, Aerts, Isabelle, Andre, Nicolas, Bertozzi-Salamon, Anne-Isabelle, Dunkel, Ira J., Hummel, Trent Ryan, Leary, Sarah, Moreno, Lucas, Russo, Mark W., Tseng, Lillian, Dasgupta, Kohinoor, Nebot, Noelia, Whitlock, James, Hargrave, Darren R
Format Journal Article
LanguageEnglish
Published 20.05.2018
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2018.36.15_suppl.10506